This subcutaneously implanted titanium osmotic mini-pump released exenatide and reduced HbA 1c by ~13 mmol/mol (1.2%) over 39 weeks compared with placebo in participants with type 2 diabetes
In clinical studies of FDA-approved semaglutide and tirzepatide, meaningful weight loss typically became evident by 8-12 weeks
Pre-treatment screening for allergies, medications, pregnancy, kidney disease, heart conditions, and fluid restrictions
No, tirzepatide can be administered at any time of day, with or without meals
Pair it with lifestyle change Staying engaged in structured nutrition and physical activity isn't optional paperwork
App-based plotters offer better day-to-day tracking integration